Alnylam Pharmaceuticals, Inc. (OQ:ALNY)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/20 Mar 2/20 Brandicourt Olivier Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,612  
Feb 28/20 Feb 26/20 Keating Laurie Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 24,554  
Feb 28/20 Feb 26/20 Poulton Jeffrey V. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 24,554 $118.05
Feb 28/20 Feb 26/20 Vaishnaw Akshay Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 27,623  
Feb 28/20 Feb 26/20 Maraganore John Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 88,240  
Feb 28/20 Feb 26/20 Greene Barry E Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 29,925  
Feb 28/20 Feb 26/20 Greenstreet Yvonne Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 27,623  
Feb 21/20 Feb 20/20 Maraganore John Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,765  
Feb 21/20 Feb 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -502 $133.42
Feb 21/20 Feb 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -18,065 $132.81
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/20 Mar 2/20 Brandicourt Olivier Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,612  
Feb 28/20 Feb 26/20 Keating Laurie Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 24,554  
Feb 28/20 Feb 26/20 Poulton Jeffrey V. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 24,554 $118.05
Feb 28/20 Jan 3/20 Poulton Jeffrey V. Indirect Ownership Common Stock J - Other transaction 19  
Feb 28/20 Feb 26/20 Vaishnaw Akshay Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 27,623  
Feb 28/20 Feb 26/20 Maraganore John Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 88,240  
Feb 28/20 Feb 26/20 Greene Barry E Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 29,925  
Feb 28/20 Feb 26/20 Greenstreet Yvonne Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 27,623  
Feb 21/20 Feb 20/20 Maraganore John Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,765  
Feb 21/20 Feb 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -502 $133.42
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ALNY

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Precigen (OQ:PGEN)